BSE filing, NSE: KFINTECH. Summary written from the filing by ALFA Finder's alert engine.
KFIN Technologies Ltd: key numbers
- Share price
- ₹855.00
- Market cap
- ₹14,781 Cr
- Revenue (annual)
- ₹1,301 Cr
- Net profit (annual)
- ₹343.7 Cr
- P/E (TTM)
- 42.4×Sector 19.7×
- Promoter holding
- 14.06%-8.76% QoQ
- FII holding
- 20.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KFIN Technologies Ltd
All →KFIN Technologies Earnings Call Transcript: Key Takeaways
Kfin reports consistent growth across all business lines despite challenging market macros.
- Call
- Guides 20% growth
KFIN Technologies Regulatory Approval
KFin Technologies' Thai subsidiary received a Foreign Business License from Thailand's Ministry of Commerce. The license enables the subsidiary to conduct permitted business activities under local law.
KFIN Technologies Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹4,018 mn, +29.9% y-o-y; EBITDA ₹1,610 mn (40.1% margin); PAT ₹1,003 mn, +7.5% y-o-y. Ascent-led international growth.
KFIN Technologies Results Update
KFin Technologies reported Q2FY27 revenue of ₹4,018.0 million, up 29.9% y-o-y, with PAT of ₹1,003.4 million. The figures come from a press release, not the full SEBI results statement.
KFIN Technologies Q2 FY27 Results: Net Profit ₹100.3 Cr, Up 7.5% YoY
KFIN Technologies Ltd reported revenue from operations of ₹401.8 Cr (+29.9% YoY) and net profit of ₹100.3 Cr (+7.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹100.3 Cr · +7.5% YoY
KFIN Technologies Other Announcement
KFin Technologies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance.
Other management change announcements
All →Fabtech Technologies Management Change
FABTECH Technologies appointed Mr. Alan Dias as Vice President - HR, a senior management personnel role, effective October 28, 2026. He brings over 24 years of human resources experience.
Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Sagarsoft (India) Management Change
Sagarsoft (India) appointed Ms. Arcot Ganeshan Monisha as Company Secretary and Compliance Officer, designated as KMP, effective 28 October 2026. Details are provided per Regulation 30 in the annexure.
Chemfab Alkalis Management Change
Chemfab Alkalis approved unaudited Q2/H1 results, committee re-designations, and appointed V. R. Raguraman as Chief Operating Officer (SMP). The senior management appointment is the filing's main business event.
Aeroflex Industries Management Change
Aeroflex Industries reports Drashti Bhil's change from Deputy CFO to CFO, plus Mustafa Kachwala's tenure completion as CFO effective 27 November 2026. Management reshuffle with no money or business event.
Chandra Prabhu International Management Change
Chandra Prabhu International resignation of Mrs. Vandana Singh, Additional Director, accepted effective close of business 28 October 2026. Filed as per SEBI Master Circular disclosure requirements.